Evidence map›Paper›PMID 40296772›Full record

ArticleBritish journal of haematology2025

Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database.

Maddalena Casale, Raffaella Colombatti, Manuela Balocco, Paola Corti, Susanna Barella, Giovanna Graziadei, Loredana Farinasso, Tommaso Mina, Simone Cesaro, Tommaso Casini and 21 more

Abstract read
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Maddalena CasaleDepartment of the Woman, the Child and General and Specialized Surgery, University "Luigi Vanvitelli", Naples, Italy.ORCID https://orcid.org/0000-0003-4740-2421
Raffaella ColombattiPediatric Hematology-Oncology Unit, Department of Women's and Child's Health, Azienda Ospedale-Università di Padova, Padua, Italy.ORCID https://orcid.org/0000-0001-9797-0457
Manuela BaloccoMicrocitemia, delle Anemie Congenite e dei Disordini del Metabolismo del Ferro, Ente Ospedaliero Ospedali Galliera, Genoa, Italy.
Paola CortiPediatric Department, Scientific Institute for Research and Healthcare (IRCCS) San Gerardo dei Tintori Foundation, Monza, Italy.
Susanna BarellaMicrocitemia and Rare Anemia Centre - ASL8, Cagliari, Italy.
Giovanna GraziadeiSC Medicina ad Indirizzo Metabolico, Scientific Institute for Research and Healthcare (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID https://orcid.org/0000-0002-6801-5730
Loredana FarinassoPaediatric Haematology Unit, Department of Paediatrics, University Hospital "Città Della Salute e della Scienza", Torino, Italy.
Tommaso MinaHemoglobinopathies Unit, Pediatric Hematology/Oncology, Scientific Institute for Research and Healthcare (IRCCS) Policlinico San Matteo, Pavia, Italy.
Simone CesaroPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Tommaso CasiniMeyer Children's Hospital IRCCS, Florence, Italy.
Fiorina GionaDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Saverio LadoganaPediatric Onco-Hematology Unit, "Casa Sollievo della Sofferenza" Hospital, IRCCS, San Giovanni Rotondo, Italy.
Pellegrina PuglieseImmunohematology and Transfusion Medicine Unit, Policlinico Umberto 1, Sapienza Università di Roma, Rome, Italy.
Lucia Dora NotarangeloDirezione Medica di Presidio, Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
Antonella SauPediatric Onco-Hematology Unit, Spirito Santo Hospital, Pescara, Italy.
Simone FerreroDepartment of Molecular Biotechnology and Health Science, University di Turin, Turin, Italy.
Giovanni PalazziPediatric Hematology and Oncology, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.
Giovanna RussoPediatric Hematology and Oncology Unit, Azienda Policlinico "Rodolico-San Marco", University of Catania, Catania, Italy.ORCID https://orcid.org/0000-0001-9369-7473
Ilaria LazzareschiDepartment of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy.
Marilena SerraInternal Medicine Unit, Thalassemia Centre, "Fazzi" Hospital, Lecce, Italy.
Saveria CampisiThalassemia Centre, Umberto I Hospital, Siracusa, Italy.
Gianluca BoscarolDepartment of Pediatrics, Central Teaching Hospital, Bolzano, Italy.
Elena FacchiniPediatric Oncology and Hematology, Scientific Institute for Research and Healthcare (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Carlo BaronciDepartment of Onco-Hematology and Cell and Gene Therapy, Scientific Institute for Research and Healthcare (IRCCS), Childrens' Hospital Bambino Gesù, Rome, Italy.
Maria Caterina PuttiDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Domenico RobertiDepartment of the Woman, the Child and General and Specialized Surgery, University "Luigi Vanvitelli", Naples, Italy.
Marzia ManiliaDepartment of the Woman, the Child and General and Specialized Surgery, University "Luigi Vanvitelli", Naples, Italy.
Antonio Ivan LazzarinoEPISTATA, Agency for Clinical Research and Medical Statistics, London, UK.
Gian Luca ForniFor Anemia Foundation, Genoa, Italy.
Silverio PerrottaDepartment of the Woman, the Child and General and Specialized Surgery, University "Luigi Vanvitelli", Naples, Italy.
Italian Network of Asplenia

Funding

American Society of Hematology
6 · The paper itself

Abstract

Splenectomy is required for many haematological conditions and causes an increased risk of severe infections and vascular events. The association between underlying haematological disease, age at splenectomy and post-splenectomy complications was explored among 1348 splenectomized patients, followed with a median follow-up time of 13 years and affected by transfusion-dependent thalassaemia, non-transfusion-dependent thalassaemia (NTDT), sickle cell anaemia (SCA), congenital haemolytic anaemias, autoimmune haematological disorders and trauma. Our main statistical approach was based on interaction analyses within competing-risk survival models. The baseline risk profile differed across diagnostic categories, with SCA being particularly susceptible to infectious complications and NTDT and SCA to vascular events (p < 0.001). The age at splenectomy did not impact on infectious risk but rather older age at splenectomy was associated with increased risk for vascular complications. Furthermore, the risk of developing a post-splenectomy complication was persistent throughout the observation period and not limited to the first 2-3 years after splenectomy. The probability of a post-splenectomy complication was highly dependent on the underlying disease and not on the age at splenectomy, so the indications for splenectomy must be based on careful assessment of pros and cons in the individual disease, with no need to delay surgery after a certain age when clinically indicated.

Indexed as

Hematologic DiseasesPostoperative ComplicationsSplenectomyAdolescentAdultAgedAge FactorsChildChild, PreschoolDatabases, FactualFemaleFollow-Up StudiesHumansInfantMaleMiddle Agedchildreninfectionpost‐splenectomy complicationssplenectomythrombosis

Identifiers

PMID40296772
PMCPMC12166330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.